Cellosaurus BT-549-Dox (CVCL_UJ22)
Cell line name | BT-549-Dox |
---|---|
Accession | CVCL_UJ22 |
Resource Identification Initiative | To cite this cell line use: BT-549-Dox (RRID:CVCL_UJ22) |
Comments | Group: Triple negative breast cancer (TNBC) cell line. Population: Caucasian. Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin). Misspelling: HTB-122-Dox; Note=Based on the ATCC catalog number of the parent cell line. Derived from site: In situ; Breast; UBERON=UBERON_0000310. |
Sequence variations |
|
Disease | Invasive breast carcinoma of no special type (NCIt: C4194) |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
Hierarchy | Parent: CVCL_1092 (BT-549) |
Sex of cell | Female |
Age at sampling | 72Y |
Category | Cancer cell line |
Publications | PubMed=7902062 |
Cross-references | |
Cell line databases/resources | cancercelllines; CVCL_UJ22 |
Encyclopedic resources | Wikidata; Q93432704 |
Entry history | |
Entry creation | 25-Feb-2019 |
Last entry update | 19-Dec-2024 |
Version number | 12 |